Dalian Bio-Chem responds to inquiry on 2024 annual report
Dalian Bio-Chem has released a detailed response to the Shanghai Stock Exchange's inquiry regarding its 2024 annual report, addressing key areas of concern. Regarding its industrial bactericide business, where sales grew to CNY 1.207 billion and accounted for 92% of revenue, the company provided a breakdown of product pricing, sales volume, and cost analysis, attributing margin changes to market competition and demand shifts. The company also disclosed information on its top international clients.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Dalian Bio-Chem publishes news
Free account required • Unsubscribe anytime